Your session is about to expire
← Back to Search
Low-Dose CT Screening for Lung Cancer (ILST Trial)
ILST Trial Summary
This trial will help determine if CT chest scans can help reduce lung cancer deaths by finding the disease early.
ILST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowILST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ILST Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have symptoms like coughing up blood, chest pain, or losing weight unexpectedly.I have cancer outside the lung that was not treated to cure.I have had pneumonia or bronchitis treated with antibiotics in the last 3 months.I am too large to fit into a standard CT scanner.I am between 55 and 80 years old.I cannot lie on my back with my arms over my head for scans.I have not taken chemotherapy or cytotoxic drugs in the last 6 months.I have been diagnosed with lung cancer before.I am currently smoking or have quit smoking for at least a year.I do not want to undergo a spiral chest CT scan.I am fully active or can carry out light work.My lung cancer risk is high, either by a model or because I've smoked a lot.
- Group 1: Single
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research study open to participants of all ages, including those under 30?
"This medical trial is only open to individuals aged 55-80. Conversely, there are 378 clinical trials available for those under 18 and 3991 research opportunities for seniors over the age of 65."
Are there any remaining vacancies for participants in this clinical experiment?
"Information hosted on clinicaltrials.gov elucidates that the recruitment phase for this medical trial has already concluded; it was first posted in April 2017 and last updated in November 2022. Despite this, there are still 4205 other trials actively looking for participants at present."
Who is eligible for enrollment in this medical experiment?
"This medical study is negotiating with 2000 people suffering from respiratory disorders, ranging in age from 55 to 80. The applicants must satisfy the following prerequisites: male or female gender, former smokers who have abstained for at least 1 year, a 6-year lung cancer risk of ≥1.51% (as determined by PLCOm2012) or >30 pack years of smoking experience and an Eastern Cooperative Oncology Group performance rating between 0 to 1."
Share this study with friends
Copy Link
Messenger